KOREA WHO
-
-
-
CEO of Yuyu Pharma
Yu Won-sang
Third-Generation Executive of Yuhan Family, Familiar with Foreign Culture, Focused on Developing Improved New Drugs
-
Last Updated on Nov 7, 2024
-
CEO of Yuyu Pharma
Life Summary
Yu Won-sang is the CEO and President of Yuyu Pharma.
His grandfather, Yoo Teuk-han, founded Yuyu Pharma and was the brother of Yoo Il-han, the founder of Yuhan Corporation. His father, Yoo Seung-pil, also served as CEO and Chairman of Yuyu Pharma.
Born in March 1974 in New York, United States, Yu attended Kent School in the U.S., then graduated from Trinity University with majors in Economics and Japanese. He earned his Master’s degree from Columbia University’s Graduate School of Business.
Before joining Yuyu Pharma, he worked abroad in consulting, financial investment, and global pharmaceutical companies, gaining experience in open-minded corporate cultures. He is now working to transform Yuyu Pharma’s organizational culture into a more horizontal, open structure.
In 2012, he leveraged big data for sales at Yuyu Pharma, becoming the first in the pharmaceutical industry to do so, which boosted sales of the children’s wound treatment product "Venoplus Gel" by nearly 50% compared to the previous year.
In 2020, he was appointed CEO and President of Yuyu Pharma, becoming the company's largest shareholder. Following the retirement of his father, Yoo Seung-pil, from the chairman role in 2021, Yu took over full responsibility for managing Yuyu Pharma.
He later recruited Park No-yong as a co-CEO to enhance management efficiency and strengthen expertise, leading Yuyu Pharma together as joint CEOs.
#YuWonSang #YuyuPharma #PharmaceuticalIndustry #CEO #BigData #CorporateCulture #YuhanCorporation #ManagementEfficiency #JointLeadership #PharmaceuticalInnovation
His grandfather, Yoo Teuk-han, founded Yuyu Pharma and was the brother of Yoo Il-han, the founder of Yuhan Corporation. His father, Yoo Seung-pil, also served as CEO and Chairman of Yuyu Pharma.
Born in March 1974 in New York, United States, Yu attended Kent School in the U.S., then graduated from Trinity University with majors in Economics and Japanese. He earned his Master’s degree from Columbia University’s Graduate School of Business.
Before joining Yuyu Pharma, he worked abroad in consulting, financial investment, and global pharmaceutical companies, gaining experience in open-minded corporate cultures. He is now working to transform Yuyu Pharma’s organizational culture into a more horizontal, open structure.
In 2012, he leveraged big data for sales at Yuyu Pharma, becoming the first in the pharmaceutical industry to do so, which boosted sales of the children’s wound treatment product "Venoplus Gel" by nearly 50% compared to the previous year.
In 2020, he was appointed CEO and President of Yuyu Pharma, becoming the company's largest shareholder. Following the retirement of his father, Yoo Seung-pil, from the chairman role in 2021, Yu took over full responsibility for managing Yuyu Pharma.
He later recruited Park No-yong as a co-CEO to enhance management efficiency and strengthen expertise, leading Yuyu Pharma together as joint CEOs.
#YuWonSang #YuyuPharma #PharmaceuticalIndustry #CEO #BigData #CorporateCulture #YuhanCorporation #ManagementEfficiency #JointLeadership #PharmaceuticalInnovation